Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study

COVAD Study Group

doi:10.1093/rheumatology/keac603

Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study

COVAD Study Group

Inflammation Biology

Tropical and infectious Disease Unit, Royal Liverpool University Hospital. Liverpool University Hospitals Foundation Trust, Liverpool, UK
Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow
Centre for Rheumatic Diseases
1Department of Hepatology, Imperial College London, London, UK. 2Institute of Liver Studies at King's College School of Medicine at King's College Hospital, London, UK. 3Institute of Human Health and Performance, University College London, London, UK. 4Department of Asthma Allergy and Lung Biology, King's College London, London, UK. 5Division of Critical Care Medicine, University of Alberta, Edmonton, Canada.
Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology Center, Amsterdam, and Zuyderland MC, Heerlen, the Netherlands.
Department of Orthodontics, Queen Mary's Hospital, Sidcup, King's College Hospital NHS Foundation Trust/King's College, London, UK.
Maulana Azad Medical College
Mymensingh Medical College
School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester , Manchester, England, UK; Manchester University NHS Foundation Trust , Manchester M13 9WL, UK
Mahatma Gandhi Mission Medical College
Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm SE-17121, Sweden; Department of Bioengineering, Marmara University, Istanbul, Turkey; Department of Bioengineering, Istanbul Medeniyet University, Istanbul, Turkey.
Royal Melbourne Hospital, Melbourne, Australia
Pomeranian Medical University in Szczecin
Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals
Cairo University
Fauji Foundation Hospital
University Hospital "Lozenetz"
National Medical Center "La Raza"
Department of Neurobiology, Caring Sciences and Society (NVS), Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden; Department of Geriatric Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.
Vall D'hebron General Hospital
University of Illinois College of Medicine Peoria
Leeds Gastroenterology Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK
Division of Rheumatology
Southport and Ormskirk Hospital NHS Trust
Departamento de Reumatología Hospital de Especialidades Dr. Antonio Fraga Mouret
Saint-Joseph University
Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Department of Internal Medicine, Rheumatology and Immunology, Universitätsklinikum Erlangen, Erlangen.
Nippon Medical School Graduate School of Medicine
Department of Evolutionary Biology and Environmental Studies, University of Zürich Zürich, Switzerland.
AIIMS All India Institute of Medical Sciences
Swami Rama Himalayan University
Clinical Immunology & Rheumatology at Columbia Asia
SMS Medical College and Hospital
Vedanta Institute of Medical Sciences
Post Graduate Institute for Education and Medical Research
AKG Memorial Hospital
Dayanand Medical College and Hospital
Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India.
Sunshine Hospitals
Arthritis and Rheumatology Clinic
KEM Hospital
AMRI Hospital
and MyungSung Christian Medical Center General Hospital and MyungSung Medical College
Dr Shenoy’s CARE (Centre for Arthritis and Rheumatism Excellence)
Department of Uro-Neurology, The National Hospital for Neurology and Neurosurgery and UCL Institute of Neurology, London, UK.
Yashoda Hospital
Niruj Rheumatology Clinic
LEDTC Clinic

Research output: Contribution to journal › Letter › peer-review

4 Citations (Scopus)

44 Downloads (Pure)

Original language	English
Pages (from-to)	E147-E152
Journal	Rheumatology (United Kingdom)
Volume	62
Issue number	5
Early online date	25 Oct 2022
DOIs	https://doi.org/10.1093/rheumatology/keac603
Publication status	Published - 1 May 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Humans
COVID-19 Vaccines
COVID-19
Myositis
Autoimmune Diseases
Vaccination

Access to Document

10.1093/rheumatology/keac603

Higher risk of short term_DEY_Accepted11October2022_GREEN AAMAccepted author manuscript, 219 KB

Cite this

@article{a2a9cc147f814edf918a379477a9239a,

title = "Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study",

keywords = "Humans, COVID-19 Vaccines, COVID-19, Myositis, Autoimmune Diseases, Vaccination",

author = "Mrinalini Dey and Naveen R and Elena Nikiphorou and Parikshit Sen and Sreoshy Saha and Lilleker, \{James B\} and Vishwesh Agarwal and Sinan Kardes and Jessica Day and Marcin Milchert and Mrudula Joshi and Tamer Gheita and Babur Salim and Tsvetelina Velikova and Gracia-Ramos, \{Abraham Edgar\} and Ioannis Parodis and \{Selva O'Callaghan\}, Albert and Minchul Kim and Tulika Chatterjee and Tan, \{Ai Lyn\} and Ashima Makol and Arvind Nune and Lorenzo Cavagna and Saavedra, \{Miguel A\} and Shinjo, \{Samuel Katsuyuki\} and Nelly Ziade and Johannes Knitza and Masataka Kuwana and Oliver Distler and Bhupen Barman and Singh, \{Yogesh Preet\} and Rajiv Ranjan and Avinash Jain and Pandya, \{Sapan C\} and Pilania, \{Rakesh Kumar\} and Aman Sharma and Manoj, \{Manesh M\} and Vikas Gupta and Kavadichanda, \{Chengappa G\} and Patro, \{Pradeepta Sekhar\} and Sajal Ajmani and Sanat Phatak and Goswami, \{Rudra Prosad\} and Chowdhury, \{Abhra Chandra\} and Mathew, \{Ashish Jacob\} and Padnamabha Shenoy and Ajay Asranna and Bommakanti, \{Keerthi Talari\} and Anuj Shukla and Pande, \{Arunkumar R\} and \{COVAD Study Group\}",

note = "Funding Information: No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this article.",

year = "2023",

month = may,

day = "1",

doi = "10.1093/rheumatology/keac603",

language = "English",

volume = "62",

pages = "E147--E152",

journal = "Rheumatology (United Kingdom)",

issn = "1462-0324",

publisher = "OXFORD UNIV PRESS",

number = "5",

}

TY - JOUR

T1 - Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities

T2 - results from the COVAD study

AU - Dey, Mrinalini

AU - R, Naveen

AU - Nikiphorou, Elena

AU - Sen, Parikshit

AU - Saha, Sreoshy

AU - Lilleker, James B

AU - Agarwal, Vishwesh

AU - Kardes, Sinan

AU - Day, Jessica

AU - Milchert, Marcin

AU - Joshi, Mrudula

AU - Gheita, Tamer

AU - Salim, Babur

AU - Velikova, Tsvetelina

AU - Gracia-Ramos, Abraham Edgar

AU - Parodis, Ioannis

AU - Selva O'Callaghan, Albert

AU - Kim, Minchul

AU - Chatterjee, Tulika

AU - Tan, Ai Lyn

AU - Makol, Ashima

AU - Nune, Arvind

AU - Cavagna, Lorenzo

AU - Saavedra, Miguel A

AU - Shinjo, Samuel Katsuyuki

AU - Ziade, Nelly

AU - Knitza, Johannes

AU - Kuwana, Masataka

AU - Distler, Oliver

AU - Barman, Bhupen

AU - Singh, Yogesh Preet

AU - Ranjan, Rajiv

AU - Jain, Avinash

AU - Pandya, Sapan C

AU - Pilania, Rakesh Kumar

AU - Sharma, Aman

AU - Manoj, Manesh M

AU - Gupta, Vikas

AU - Kavadichanda, Chengappa G

AU - Patro, Pradeepta Sekhar

AU - Ajmani, Sajal

AU - Phatak, Sanat

AU - Goswami, Rudra Prosad

AU - Chowdhury, Abhra Chandra

AU - Mathew, Ashish Jacob

AU - Shenoy, Padnamabha

AU - Asranna, Ajay

AU - Bommakanti, Keerthi Talari

AU - Shukla, Anuj

AU - Pande, Arunkumar R

AU - COVAD Study Group

N1 - Funding Information: No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this article.

PY - 2023/5/1

Y1 - 2023/5/1

KW - Humans

KW - COVID-19 Vaccines

KW - COVID-19

KW - Myositis

KW - Autoimmune Diseases

KW - Vaccination

UR - https://www.scopus.com/pages/publications/85166154170

U2 - 10.1093/rheumatology/keac603

DO - 10.1093/rheumatology/keac603

M3 - Letter

C2 - 36282492

AN - SCOPUS:85166154170

SN - 1462-0324

VL - 62

SP - E147-E152

JO - Rheumatology (United Kingdom)

JF - Rheumatology (United Kingdom)

IS - 5

ER -

Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study

UN SDGs

Keywords

Access to Document

Other files and links

Cite this